These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10542936

  • 21. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I, Altaras MM, Beyth Y, Shapira J, Figer A, Tepper R, Cordoba M, Yigal D, Bernheim J.
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [Abstract] [Full Text] [Related]

  • 22. Effects of hormone therapy on the endometrium.
    Deligdisch L.
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [Abstract] [Full Text] [Related]

  • 23. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
    Sivridis E, Giatromanolaki A.
    J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
    [Abstract] [Full Text] [Related]

  • 24. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.
    Mäentausta O, Svalander P, Danielsson KG, Bygdeman M, Vihko R.
    J Clin Endocrinol Metab; 1993 Oct; 77(4):913-8. PubMed ID: 8408465
    [Abstract] [Full Text] [Related]

  • 25. The effects of progesterone and progestins on endometrial proliferation.
    Moyer DL, Felix JC.
    Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
    [Abstract] [Full Text] [Related]

  • 26. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
    Duffy SR, Taylor L.
    Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
    [Abstract] [Full Text] [Related]

  • 27. K-ras mutation in tamoxifen-related endometrial polyps.
    Hachisuga T, Miyakawa T, Tsujioka H, Horiuchi S, Emoto M, Kawarabayashi T.
    Cancer; 2003 Nov 01; 98(9):1890-7. PubMed ID: 14584071
    [Abstract] [Full Text] [Related]

  • 28. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
    Miranda SP, Traiman P, Cândido EB, Lages EL, Freitas GF, Lamaita RM, Vidigal PV, da Silva Filho AL.
    Int J Gynecol Cancer; 2010 Dec 01; 20(9):1525-30. PubMed ID: 21119367
    [Abstract] [Full Text] [Related]

  • 29. Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?
    Xuebing P, TinChiu L, Enlan X, Jing L, Xiaowu H.
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov 01; 159(1):198-203. PubMed ID: 21726930
    [Abstract] [Full Text] [Related]

  • 30. Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
    de Carvalho S, Campaner AB, Lima SM, Silva MA, Ribeiro PA.
    Anal Quant Cytol Histol; 2011 Apr 01; 33(2):61-7. PubMed ID: 21980607
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Estrogen and progesterone receptors of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen.
    Cohen I, Shapira J, Beyth Y, Bernheim J, Tepper R, Cordoba M, Altaras MM.
    Gynecol Obstet Invest; 1998 Apr 01; 45(2):126-31. PubMed ID: 9517806
    [Abstract] [Full Text] [Related]

  • 33. [Tamoxifen and endometrial pathology].
    Negoiţă M, Terinte C, Mihailovici MS.
    Rev Med Chir Soc Med Nat Iasi; 2010 Apr 01; 114(4):1114-7. PubMed ID: 21500468
    [Abstract] [Full Text] [Related]

  • 34. Effects of selective oestrogen receptor modulators on proliferation in tissue cultures of pre- and postmenopausal human endometrium.
    Punyadeera C, Kamps R, Defrère S, Dijcks F, de Goeij A, Ederveen A, Dunselman G, Groothuis P.
    J Steroid Biochem Mol Biol; 2008 Nov 01; 112(1-3):102-9. PubMed ID: 18832036
    [Abstract] [Full Text] [Related]

  • 35. Expression patterns of Aurora A and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model.
    Calcagno A, Grassi T, Mariuzzi L, Marzinotto S, Londero AP, Orsaria M, Beltrami CA, Marchesoni D.
    Hum Reprod; 2011 Oct 01; 26(10):2731-41. PubMed ID: 21840910
    [Abstract] [Full Text] [Related]

  • 36. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model.
    Bläuer M, Heinonen PK, Rovio P, Ylikomi T.
    Eur J Pharmacol; 2008 Sep 11; 592(1-3):13-8. PubMed ID: 18638473
    [Abstract] [Full Text] [Related]

  • 37. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF, Lin HH, Torng PL, Huang SC.
    Gynecol Oncol; 1997 Aug 11; 66(2):233-7. PubMed ID: 9264568
    [Abstract] [Full Text] [Related]

  • 38. Cell kinetic study of the endometrium by nonisotopic in situ hybridization for histone H3 messenger RNA and immunohistochemistry for Ki-67 and for estrogen and progesterone receptors.
    Hayama M, Ota H, Toki T, Ishii K, Honda T, Momose M, Nakata R.
    Anat Rec; 2002 Apr 01; 266(4):234-40. PubMed ID: 11920386
    [Abstract] [Full Text] [Related]

  • 39. Does tamoxifen change oestrogen and progesterone receptor expression in the endometrium and breast?
    Karck U, Kommoss F.
    Eur J Cancer; 2000 Sep 01; 36 Suppl 4():S45-6. PubMed ID: 11056315
    [Abstract] [Full Text] [Related]

  • 40. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF, Pizer ES, Ronnett BM, Kurman RJ.
    Hum Pathol; 1998 Jun 01; 29(6):551-8. PubMed ID: 9635673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.